61 – 70 of 130
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD)
- Contribution to journal › Article
-
Mark
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
- Contribution to journal › Article
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
- Contribution to journal › Article
-
Mark
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
- Contribution to journal › Article
-
Mark
Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
(2016) 20th International Congress of Parkinson's Disease and Movement Disorders In Movement Disorders 31(Suppl. S2). p.282-282
- Contribution to journal › Published meeting abstract
-
Mark
Integrated Safety of Levodopa-Carbidopa Intestinal Gel From Prospective Clinical Trials.
- Contribution to journal › Article
- 2015
-
Mark
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Final 12-Month, Open-Label Results
- Contribution to journal › Article
-
Mark
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
- Contribution to journal › Article
-
Mark
Zooming in on the small: The plasticity of striatal dendritic spines in l-DOPA-Induced dyskinesia.
- Contribution to journal › Article
-
Mark
King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.
- Contribution to journal › Article
